Data and insights on postmarket quality from medtech quality leaders

The 2025 Veeva MedTech Postmarket Quality Benchmark surveyed over 100 industry leaders to reveal key challenges and opportunities for driving proactive quality and compliance. This comprehensive report explores current processes, identifies critical barriers, and reveals the technology-driven strategies that are shaping the future of quality management.

51%

rely on manual processes to manage postmarket quality

38%

identify proactive and risk-based quality management as the leading driver for transformation

48%

report lack of systems is their primary barrier to achieving proactive quality